Medical Xpress
Hepatocarcinoma is the most commonly diagnosed form of liver cancer. It is an aggressive, fast growing cancer with a 5-year survival rate of only 15%. Thomas Jefferson University researcher Gyorgy Hajnoczky, MD/Ph.D., and his team recently found that a protein in mitochondria called VDAC2, may be a key player in making liver cancer cells more susceptible to cell death than normal liver tissue…
Read More
Mitochondrial protein may improve selective liver cancer treatment
Hepatocarcinoma is the most commonly diagnosed form of liver cancer. It is an aggressive, fast growing cancer with a 5-year survival rate of only 15%. Thomas Jefferson University researcher Gyorgy Hajnoczky, MD/Ph.D., and his team recently found that a protein in mitochondria called VDAC2, may be a key player in making liver cancer cells more